ITRE reaches agreement on FP7

The European Parliament's Industry, Research and Energy Committee (ITRE) has adopted, in a second reading, a set of comprise amendments on the Seventh Framework Programme (FP7), which were agreed upon in informal meetings with the Council.

The 39 new amendments deal with issues such as the structure of the European Research Council (ERC) and the proposed Risk Sharing Finance Facility (RSFF).

MEPs agreed on an amendment on renewable and end use energy, which foresees a 'major part' of the budget from FP7's energy theme going to the field, instead of two thirds as proposed by the Parliament in its first reading. According to ITRE, special attention will be devoted to the coordination of issues linked to rational and efficient use of energy in FP7 and in other EU policies.

A compromise was also reached regarding the administrative costs of the ERC, which should now not exceed 5% - MEPs had originally asked for a limit of 3%. On the issue of the Parliament's involvement in the interim evaluation of the ERC, it was agreed to opt for co-decision procedure in case changes in the structure of ERC become necessary.

ITRE also endorsed amendments on the rules of participation for companies, research centres and universities, as well as the RSFF, which is designed to encourage bank lending to research projects. Initially, the Council had planned to allocate €1 billion from the FP7 budget to finance RSFF. However, under the amendment, a lower contribution of €500 million is foreseen until 2010, with the possibility of releasing the additional €500 million after a review.

On the European Institute of Technology (EIT), the committee stressed that no money from FP7 should be used to finance the proposed structure. Only administrative costs directly associated with research projects may be covered.

The amended text will be put to the vote at a Parliament plenary session, due to be held on 29 November, before it is put to the Council on 5 December.

If all goes to plan, the first calls for proposals for FP7 projects could be published by December 2006, with closing dates in March 2007. Following an evaluation period, the first FP7 projects could start as early as the end of 2007 or early 2008

For further information on FP7, please visit:
http://cordis.europa.eu/fp7/

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...